Pharmacy benefit manager Optum Rx plans to launch Clear Trend Guarantee in 2025 to allow employers and health insurers to more easily manage their drug spending, while creating more predictability for patients around costs.

The new lawsuit, which follows similar litigation filed by AdventHealth and Allegiance Health Management, names Aetna, Elevance Health, Cigna, UnitedHealth Group and Humana as "co-conspirators" in the "MultiPlan cartel."

An increasing number of employers are offering their employees access to psychedelic-assisted psychotherapy, as part of their mental health coverage to treat depression, anxiety and PTSD - and to lower costs.

With drug shortages at an all-time high, the Senate Finance Committee wants to create a new program to incentivize improved contracting and purchasing practices in the supply chain by offering bonuses to hospitals and providers.

With concerns that costs could reach more than $1 billion over the next 6 years, North Carolina opted to stop coverage for the pricey new GLP-1s, saying the contracts between the drugmakers and the PBMs "are all-or-nothing."

The agency has stepped up its campaign against drugmakers' improper listing of patents in the FDA's Orange Book, which it contends are ploys intended to delay generic competition, by disputing junk patent listings for 300 drugs.

The investment firm is among 600 organizations worldwide whose pension funds and benefits plan providers had their participants' data breached recently, and should be "a wake-up call" to all plan sponsors, say industry experts.

Fifty-three percent of Gen Z freelancers perform freelance work for at least 40 hours per week across a portfolio of different types of work.